Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Clarity Pharmaceuticals Ltd market cap is $445.83M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clarity Pharmaceuticals Ltd 52 week high is $2.89 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clarity Pharmaceuticals Ltd 52 week low is $1.00 as of November 21, 2026.
Clarity Pharmaceuticals Ltd stock price today is $1.20.
Clarity Pharmaceuticals Ltd stock price yesterday was $1.25.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Clarity Pharmaceuticals Ltd's P/E ratio is -6.06.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Clarity Pharmaceuticals Ltd P/B ratio is 3.4568.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Clarity Pharmaceuticals Ltd 50-day moving average is $1.33.